BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31356244)

  • 1. Orolingual Angioedema After Tissue Plasminogen Activator Administration in Patients Taking Angiotensin-Converting Enzyme Inhibitors.
    Burd M; McPheeters C; Scherrer LA
    Adv Emerg Nurs J; 2019; 41(3):204-214. PubMed ID: 31356244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration.
    Pahs L; Droege C; Kneale H; Pancioli A
    Ann Emerg Med; 2016 Sep; 68(3):345-8. PubMed ID: 27174372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orolingual Angioedema After Tissue Plasminogen Activator Administration in Patients Taking Angiotensin-Converting Enzyme Inhibitors.
    Adv Emerg Nurs J; 2019; 41(3):E1-E2. PubMed ID: 31356245
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke.
    Hurford R; Rezvani S; Kreimei M; Herbert A; Vail A; Parry-Jones AR; Douglass C; Molloy J; Alachkar H; Tyrrell PJ; Smith CJ
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):520-3. PubMed ID: 25016564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use.
    Lin SY; Tang SC; Tsai LK; Yeh SJ; Hsiao YJ; Chen YW; Chen KH; Yip BS; Shen LJ; Wu FL; Jeng JS
    Eur J Neurol; 2014 Oct; 21(10):1285-91. PubMed ID: 24909847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioedema after tPA: what neurointensivists should know.
    Fugate JE; Kalimullah EA; Wijdicks EF
    Neurocrit Care; 2012 Jun; 16(3):440-3. PubMed ID: 22311232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke.
    Hill MD; Lye T; Moss H; Barber PA; Demchuk AM; Newcommon NJ; Green TL; Kenney C; Cole-Haskayne A; Buchan AM
    Neurology; 2003 May; 60(9):1525-7. PubMed ID: 12743244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audit report and systematic review of orolingual angioedema in post-acute stroke thrombolysis.
    Lekoubou A; Philippeau F; Derex L; Olaru A; Gouttard M; Vieillart A; Kengne AP
    Neurol Res; 2014 Jul; 36(7):687-94. PubMed ID: 24620962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioedema from recombinant TPA administration: case report and pathophysiology review.
    Foster-Goldman A; McCarthy D
    Am J Ther; 2013; 20(6):691-3. PubMed ID: 24247033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke.
    Engelter ST; Fluri F; Buitrago-Téllez C; Marsch S; Steck AJ; Rüegg S; Lyrer PA
    J Neurol; 2005 Oct; 252(10):1167-70. PubMed ID: 16184341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke.
    Rafii MS; Koenig M; Ziai WC
    Neurology; 2005 Dec; 65(12):1906. PubMed ID: 16380611
    [No Abstract]   [Full Text] [Related]  

  • 12. [Orolingual Angioedema after Recombinant Tissue Plasminogen Activator Treatment in Acute Cardiogenic Cerebral Embolism Patient Using Olmesartan: A Case Report].
    Minami C; Araki R; Hamamoto T; Yamada H
    Yakugaku Zasshi; 2022; 142(1):85-89. PubMed ID: 34980751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipsilateral orolingual angioedema following rhTNK-tPA administration for acute ischemic stroke.
    Shi G; Lv J; Wu W; Zhou R
    Am J Emerg Med; 2024 Mar; 77():231.e1-231.e3. PubMed ID: 38272772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Orolingual angioedema as complication after rt-PA in stroke patient treated with ACE inhibitor].
    Okada Y; Shibazaki K; Sakai K; Kobayashi K; Iguchi Y; Kimura K
    Rinsho Shinkeigaku; 2008 Apr; 48(4):278-80. PubMed ID: 18453163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue Plasminogen Activator-Induced Angioedema Involving a Posterior Cerebral Artery Infarct: A Case Presentation.
    Duymun S; Reddy V; Bentley E; Bose-Kolanu A
    Am J Case Rep; 2021 Jan; 22():e927137. PubMed ID: 33441533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angioedema after the Administration of tPA for Ischemic Stroke in Patients Taking Angiotensin Converting Enzyme Inhibitors.
    Bedel C; Balci E; Korkut M
    Neurol India; 2022; 70(2):799-800. PubMed ID: 35532667
    [No Abstract]   [Full Text] [Related]  

  • 17. Alteplase associated Orolingual angioedema: A case report and literature review.
    Qi X; Lin H
    Medicine (Baltimore); 2022 Dec; 101(52):e32474. PubMed ID: 36596071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.
    Cheong E; Dodd L; Smith W; Kleinig T
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e36-e37. PubMed ID: 29097062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
    Fok JS; Katelaris CH; Brown AF; Smith WB
    Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of alteplase-induced orolingual angioedema by means of icatibant].
    Mas-Serrano M; Garcia-Pastor A; Tornero-Molina P; Vazquez-Alen P; Palacios-Mendoza MA; Gil-Nunez AC
    Rev Neurol; 2019 Sep; 69(6):261-262. PubMed ID: 31497871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.